Literature DB >> 12901848

Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis.

Ryan D Erwert1, Kristine T Eiting, Joan C Tupper, Robert K Winn, John M Harlan, Douglas D Bannerman.   

Abstract

Shiga toxin (Stx) has been implicated in the pathogenesis of several human and animal disease states. A key host target of Stx is the endothelial cell. Stx induces endothelial cell apoptosis through a mechanism that remains unknown. In the present report, we demonstrate that Stx-1 and Stx-2 inhibit endothelial cell expression of the anti-apoptotic Bcl-2 family member, Mcl-1. Decreased expression of Mcl-1 preceded the onset of Stx-induced apoptosis. Further, Stx-1-induced decrements in Mcl-1 expression correlated in a dose-dependent manner with sensitization to Stx-1-induced apoptosis. Finally, inhibition of Mcl-1 degradation with the proteasome inhibitor, lactacystin, protected against Stx-1-induced apoptosis. These combined data suggest a role for Mcl-1 in protecting endothelial cells against Stx-1-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901848     DOI: 10.1016/s0882-4010(03)00100-1

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  17 in total

Review 1.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

Review 2.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

3.  Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance.

Authors:  Helen M Marriott; Colin D Bingle; Robert C Read; Karen E Braley; Guido Kroemer; Paul G Hellewell; Ruth W Craig; Moira K B Whyte; David H Dockrell
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 4.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

5.  Biochemical, pathological and oncological relevance of Gb3Cer receptor.

Authors:  D Đevenica; V Čikeš Čulić; A Vuica; A Markotić
Journal:  Med Oncol       Date:  2010-11-11       Impact factor: 3.064

Review 6.  Different types of cell death induced by enterotoxins.

Authors:  Chiou-Feng Lin; Chia-Ling Chen; Wei-Ching Huang; Yi-Lin Cheng; Chia-Yuan Hsieh; Chi-Yun Wang; Ming-Yuan Hong
Journal:  Toxins (Basel)       Date:  2010-08-11       Impact factor: 4.546

Review 7.  Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.

Authors:  Parviz Behnam-Motlagh; Andreas Tyler; Kjell Grankvist; Anders Johansson
Journal:  Toxins (Basel)       Date:  2010-10-25       Impact factor: 4.546

8.  Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity.

Authors:  Verónica I Landoni; Pablo Schierloh; Marcelo de Campos Nebel; Gabriela C Fernández; Cecilia Calatayud; María J Lapponi; Martín A Isturiz
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

9.  Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin.

Authors:  Takayuki Hattori; Miho Watanabe-Takahashi; Nobumichi Ohoka; Takashi Hamabata; Koichi Furukawa; Kiyotaka Nishikawa; Mikihiko Naito
Journal:  FEBS Open Bio       Date:  2015-06-12       Impact factor: 2.693

10.  Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.

Authors:  Kiyomi Takahashi; Nobuaki Funata; Fusahiro Ikuta; Shigehiro Sato
Journal:  J Neuroinflammation       Date:  2008-03-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.